Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03762954 · ClinicalTrials.gov registry record
Assessment of Cognitive and Functional Impairment in Older Patients After ERCP
A clinical trial of Cognitive Impairment, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 215
- Enrollment target
- 1
- Study location
NCT03762954 is a study of Cognitive Impairment that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 215 participants, below the 664-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03762954, a study of Cognitive Impairment, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 215 participants
- Enrollment target
- 1
- Study location
Study Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional endoscopy procedure utilized in the therapeutic management of pancreatobiliary diseases including gallstones, bile duct strictures, leaks and infections, pancreatitis, and cancers of the bile duct or pancreas. ERCP is classified as a high risk procedure. Potential adverse events directly attributable to the technical aspects of ERCP include pancreatitis, hemorrhage, infection, and bowel wall perforation. Other potential adverse events of ERCP may be less apparent and/or unknown, such as risk of neurocognitive dysfunction. Overall, neurocognitive dysfunction after medical procedures impacts quality of life, functional disability, depression, and caregiver and societal burden. The prevalence of postoperative neurocognitive dysfunction and disability following interventional endoscopy procedures such as ERCP has not been reported. This prospective observational study is designed to assess the prevalence of cognitive impairment and functional disability after ERCP and endoscopic ultrasound (EUS) procedures in older patients, and to assess whether specific patient and/or procedural factors are associated with increased risk of adverse outcomes.
Conditions Studied
Interventions
- OTHER Neurocognitive function assessment
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2024-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03762954
The ClinicalTrials.gov registry entry for NCT03762954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 664-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (68% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Neurocognitive function assessment is the first listed.
NCT03762954 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03762954 about?
NCT03762954 is a clinical study titled "Assessment of Cognitive and Functional Impairment in Older Patients After ERCP". Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional endoscopy procedure utilized in the therapeutic management of pancreatobiliary diseases including gallstones, bile duct strictures, leaks and infections, pancreatitis, and cancers of the bile duct or pancreas. ERCP is classif...
What is the current status of trial NCT03762954?
This trial is currently completed. The enrollment target is 215 participants. The study started on 2019-02-08. Estimated completion is 2024-04-04.
What conditions does trial NCT03762954 study?
This clinical trial studies the following conditions: Cognitive Impairment.
What interventions are being tested in trial NCT03762954?
The interventions under investigation include: Neurocognitive function assessment (OTHER).
Who is sponsoring clinical trial NCT03762954?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03762954 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Biomarker Exploration in Aging, Cognition and Neurodegeneration
RECRUITING · Phase 3
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.